Immediate Impact
18 standout
Citing Papers
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
2024 Standout
Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study
2024 Standout
Works of Amber Winn being referenced
Seasonality of Respiratory Syncytial Virus — United States, 2017–2023
2023 Standout
Respiratory syncytial virus‐associated deaths in the United States according to death certificate data, 2005 to 2016
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Amber Winn | 114 | 166 | 24 | 63 | 11 | 224 | |
| Terrence Lee | 59 | 91 | 50 | 33 | 17 | 285 | |
| Donatien Serge Mbaga | 100 | 88 | 16 | 37 | 16 | 190 | |
| Ilada Thongpan | 62 | 146 | 31 | 41 | 15 | 178 | |
| Sivan Perl | 102 | 70 | 12 | 34 | 13 | 281 | |
| Jean Li‐Kim‐Moy | 83 | 172 | 62 | 21 | 17 | 263 | |
| Livia Piccioni | 64 | 126 | 25 | 39 | 15 | 186 | |
| Clement Lewa | 101 | 179 | 45 | 74 | 10 | 227 | |
| Agnieszka Zareba | 120 | 228 | 21 | 74 | 12 | 255 | |
| Najla Al‐Sonboli | 144 | 143 | 57 | 20 | 13 | 202 | |
| Laura S Stewart | 106 | 73 | 13 | 34 | 18 | 167 |
All Works
Loading papers...